RNF183 Induces Polarization of M2 Macrophages by Regulating Ubiquitination of PML and Promotes Lung Cancer

Lu Xu1, Chenlin Lu1

  • 1Department of Respiratory Medicine, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, China.

Abstract

Insights

RING finger 183 (RNF183) drives lung cancer progression by promoting M2 macrophage polarization. This occurs through RNF183-mediated ubiquitination of the promyelocytic leukemia (PML) protein, impacting tumor growth and invasion.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Macrophage polarization significantly influences lung cancer development.
  • M2 macrophages are implicated in accelerating lung cancer progression.

Purpose of the Study:

  • To elucidate the mechanism by which M2 macrophages promote lung cancer progression.
  • To investigate the role of RING finger 183 (RNF183) in M2 macrophage polarization and lung cancer growth.

Main Methods:

  • THP-1 cells were differentiated into M2 macrophages using IL-4/IL-13.
  • Co-culture systems with lung cancer cells and M2 macrophage-conditioned medium were established.
  • Techniques included flow cytometry, qPCR, western blots, CCK-8, clone formation, wound healing, transwell, co-immunoprecipitation, and cycloheximide assays to study RNF183 and PML interactions.

Main Results:

  • RNF183 was identified as a key regulator of M2 macrophage polarization.
  • RNF183 enhances lung cancer cell proliferation, migration, and invasion by stimulating M2 polarization.
  • Mechanistically, RNF183 targets PML for ubiquitination, down-regulating PML and promoting M2 polarization; RNF183 knockdown inhibited cancer progression, which was reversed by PML knockdown.

Conclusions:

  • RNF183 is a novel regulator of M2 macrophage polarization in lung cancer.
  • The RNF183/PML axis, involving ubiquitination, influences macrophage phenotype and the tumor microenvironment.
  • Targeting the RNF183/PML pathway presents a potential immunomodulatory strategy for lung cancer treatment.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...